Evaluation of the Cavidi ExaVir Load Assay (Version 3) for Plasma Human Immunodeficiency Virus Type 1 Load Monitoring
Journal Of Clinical MicrobiologyVicki Greengrass +72009Journals
We evaluated the new low-cost ExaVir Load (version 3) reverse transcriptase viral load assay against the Roche Cobas Amplicor assay. Results for samples tested using the reverse transcriptase assay correlated well with those obtained with the Roche assay (r = 0.85;n = 202). The version 3 reverse transcriptase assay shows improved sensitivity compared to the previous version.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support